Most experts who develop cancer treatment guidelines have ties to industry

(By Ed Silverman for STAT)

As cancer treatments become both more innovative and costlier, a new study finds that most of the physicians and researchers who help develop treatment guidelines have financial ties to drug and device makers. And the findings are only the latest to raise questions about the extent to which such relationships may ultimately influence decisions for treating patients. Continue reading article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.